David Patience
Patrimonio netto: 1 M $ in data 31/08/2026
Patrimonio netto: 1 M $ in data 31/08/2026
David Patience is Chief Financial Officer at TriSalus Life Sciences, Inc. since 2025.
Previously, Chief Financial Officer at Accelerate Diagnostics, Inc. from 2023 to 2025.
Education includes an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Leeds School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 261.107 ( 0,42% ) | 1 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Direttore Finanziario/CFO | 01/07/2025 |
| Società | Posizione | Fine |
|---|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Direttore Finanziario/CFO | 30/06/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leeds School of Business
The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale